Merck & Co., Inc. has agreed to pay $4.85 billion to resolve Vioxx-related claims in which a claimant has suffered a heart attack, sudden cardiac death, or stroke.

After more than five years of litigation, Merck has agreed to settle some 27,000 Vioxx lawsuits for a record $4.85 billion.

The litigation involving thousands of Vioxx lawsuits consolidated in U.S. District Court, under Judge Fallon related to the pain reliever, Vioxx, is going to be announced by Merck shortly, at a formal status conference.

The Vioxx settlement is larger than the $3.75 billion Fen-Phen settlement.

An official Vioxx Settlement Calculator has been developed to help individuals understand the complicated settlement criteria.

For more information on the landmark vioxx settlement, visit www.beasleyallen.com.

Other Related Articles

• Merck To Fund Vioxx Settlement In August
• A Look at Some Key Elements in the Vioxx Litigation
• Merck Agrees To $58 Million Settlement Over Vioxx Ad Claims
• Vioxx Settlement Update
• Vioxx Settlement Program Update